Clinical Trial Update: A Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Allergic Conjunctivitis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating OTX-DP for allergic conjunctivitis has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis

Drugs mentioned

• OTX-DP

Snippet

Sponsor: Ocular Therapeutix, Inc. | Conditions: Allergic Conjunctivitis | Phase 3 | Status: COMPLETED | Results posted: 2021-10-07